Clinical Trials
- Alzheimer's
A Phase 3b/4 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Verify the Clinical Benefit of Aducanumab (BIIB037) in Participants With Alzheimer's Disease (ENVISION)
- Ages60 years - 85 years
- GenderBoth
- Aging, Mental Health & Behavioral Research
A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy
- Ages50 years - 85 years
- GenderBoth
- Alzheimer's
AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
- Ages55 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
Imaging mGluR5 and synaptic density in psychiatric disorders
- Ages18 years - 80 years
- GenderBoth
- Mental Health & Behavioral Research
Studying the Adult Brain